Clinical experience of treating primary membranous nephropathy based on the theory of imbalance of the body fluid chain gasification

LIU Xianli; LIU Baoli; JIA Yingmin

doi:10.16025/j.1674-1307.2025.02.002

您当前的位置：

首页 >

文章列表页 >

Clinical experience of treating primary membranous nephropathy based on the theory of imbalance of the body fluid chain gasification

更新时间：2025-03-19

- Clinical experience of treating primary membranous nephropathy based on the theory of imbalance of the body fluid chain gasification
- Beijing Journal of Traditional Chinese Medicine Vol. 44, Issue 2, Pages: 124-127(2025)
- 作者机构：
  
  1.北京中医医院顺义医院肾病科，北京 101300
  2.首都医科大学附属北京中医医院，北京 100010
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2025.02.002
  CLC：
- Received：14 December 2024，
  
  Published：25 February 2025
- 稿件说明：
移动端阅览
刘先利，刘宝利，贾英民.基于津液链气化失调论治原发性膜性肾病的临床体会［J］.北京中医药，2025，44（2）：124-127.

LIU Xianli,LIU Baoli,JIA Yingmin.Clinical experience of treating primary membranous nephropathy based on the theory of imbalance of the body fluid chain gasification[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(02):124-127.
刘先利，刘宝利，贾英民.基于津液链气化失调论治原发性膜性肾病的临床体会［J］.北京中医药，2025，44（2）：124-127. DOI： 10.16025/j.1674-1307.2025.02.002.

LIU Xianli,LIU Baoli,JIA Yingmin.Clinical experience of treating primary membranous nephropathy based on the theory of imbalance of the body fluid chain gasification[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(02):124-127. DOI： 10.16025/j.1674-1307.2025.02.002.

摘要

膜性肾病是引起成人肾病综合征的最常见病因，目前，原发性膜性肾病的发病机制仍不明确，因而缺乏有效的药物治疗。本文基于临床实践，以中医津液链为理论基础，对其概念及运行规律进行阐述，重点梳理津液链气化失调的病因病机、症状特点、治则治法，并结合原发性膜性肾病的特点，详细阐述从津液链气化失调论治原发性膜性肾病的理法方药体系。为进一步深入规范研究原发性膜性肾病的中医诊治体系奠定基础。

Abstract

Membranous nephropathy is the most common cause of nephrotic syndrome in adults. Currently， the pathogenesis of primary membranous nephropathy remains unclear， leading to a lack of effective drug treatments. Based on clinical practice and the traditional Chinese medicine （TCM） theory of the body fluid chain， this study elucidates its concept and operational mechanisms， with a focus on the etiology， pathogenesis， symptom characteristics， treatment principles， and therapeutic approaches related to body fluid chain gasification disorders. Considering the characteristics of primary membranous nephropathy， this study provides a detailed exposition of the theoretical framework， treatment principles， and medicinal approach for managing the disease from the perspective of body fluid chain gasification disorders. These findings lay the foundation for further in-depth and standardized research on the TCM-based diagnosis and treatment system for primary membranous nephropathy.

关键词

Keywords

references

刘莎莎 , 桑晓红 , 刘珍 . 特发性膜性肾病诊断及治疗研究进展 [J ] . 中华实用诊断与治疗杂志 , 2017 , 31 ( 1 ): 82 - 84 ．

ICHIKAWA K , KONTA T , SATO H , et al . Membranous nephropathyin Japan:analysis of the Japan Renal Biopsy Registry(JRBR) [J ] . Clin Exp Nephrol , 2012 , 16 ( 4 ): 557 - 563 ．

任松 , 李贵森 . 特发性膜性肾病的发病机制研究 [J ] . 实用医院临床杂志 , 2017 , 14 ( 2 ): 109 - 112 .

VOLOVĂT C , CÃRUNTU I , COSTIN C , et al . Changes in the histologicalspectrum of glomerular diseases in the past 16 years in the North-Eastern region of romania [J ] . BMC Nephrol , 2013 , 14 : 148 ．

NANGAKU M , SHANKLAND SJ , COUSER WG . Cellular response to injury in membranous nephropathy [J ] . J Am Soc Nephrol , 2005 , 16 : 1195 - 1204 .

FERVENZA FC , SETHI S , SPECKS U . Idiopathic membranous nephropathy:diagnosis and treatment [J ] . Clin J Am Soc Nephrol , 2008 , 3 : 905 - 919 .

HOFSTRA JM , FERVENZA FC , WETZELS JFM . Treatment of idiopathic membranous nephropathy [J ] . Nat Rev Nephrol , 2013 , 5 ( 9 ): 443 - 458 .

AHLMANN M , HEMPEL G . The effect of cyclophosphamide on the i-mmune system:implications for clinical cancer therapy [J ] . Cancer Chemo Pharm , 2016 , 39 ( 78 ): 661 - 671 .

SHAH SR , ALTAF A , ARSHAD MH , et al . Use of cyclosporine therapy insteroid resistant nephrotic syndrome(SRNS):A Review [J ] . Global J Health Sci , 2015 , 8 ( 4 ): 136 - 141 .

刘宝利 , 赵进喜 , 刘玉宁 , 等 . 论膜性肾病的中医概念与中医药治疗 [J ] . 北京中医药 , 2019 , 38 ( 3 ): 195 - 199 .

CHEN Y , DENG Y , NI Z , et al . Efficacy and safety of traditional Chinese medicine(Shenqi particle)for patients with idiopathic membranous nephropathy:a multicenter randomized controlled clinical trial [J ] . Am J Kidney Dis , 2013 , 33 ( 62 ): 1068 - 1076 .

刘渡舟 . 谈谈人体的津液链 [J ] . 陕西中医 , 1980 ,( 4 ): 1 - 2,6 .

赵启涵 , 戴浩然 , 刘文斌 , 等 . 从阳虚癥积辨识特发性膜性肾病 [J ] . 北京中医药 , 2021 , 40 ( 2 ): 110 - 113 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰